Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Eszter Kiss is active.

Publication


Featured researches published by Eszter Kiss.


Pathology Research and Practice | 2012

Gonadoblastoma: Case report of two young patients with isochromosome 12p found in the dysgerminoma overgrowth component in one case

Yi Che Changchien; Irén Haltrich; Tamás Micsik; Eszter Kiss; László Fónyad; Gergo Papp; Zoltán Sápi

Gonadoblastomas are unusual neoplasias that frequently appear in the dysgenetic gonads of women with chromosome Y anomaly. We present two cases of gonadoblastoma associated with complete gonadal dysgenesis and Turner syndrome, respectively, with dysgerminoma overgrowth found in one case. We were interested in the DNA ploidy, the presence of Y chromosome DNA sequence and the status of chromosome 12p arm among the tumor cells. We performed cytophotometry to analyze the DNA content and fluorescence in situ hybridization (FISH) to identify the Y chromosome and the isochromosome 12p within the tumor cells. The cytophotometric result showed diploid DNA content in gonadoblastoma, whereas dysgerminoma revealed aneuploid DNA. The FISH result revealed Y chromosome DNA sequence within gonadoblastoma and dysgerminoma. Isochromosome 12p was identified in dysgerminoma, but not in gonadoblastoma. We conclude that gonadoblastoma and dysgerminoma have a strong association with the Y chromosome, and dysgerminoma overgrowth is due to further chromosomal aberrations, such as isochromosome 12p. Histological, immunohistocheimcal and molecular studies should render the correct diagnosis. Identifying dysgerminoma overgrowth is crucial since it is associated with adverse prognosis and requires additional therapy.


Journal of Pharmaceutical and Biomedical Analysis | 2018

DNA binding of sunitinib: Spectroscopic evidence via circular dichroism and nuclear magnetic resonance

Eszter Kiss; Arash Mirzahosseini; Ágnes Hubert; Attila Ambrus; László Őrfi; Péter Horváth

Sunitinib is a non-selective tyrosine kinase inhibitor, but in its chemical structure there can be discovered certain features, which suggest the ability to bind to DNA. These elements are the planar aromatic system and the tertiary amine function, which is protonated at the pH of the organism. In this study, the binding of the drug sunitinib to DNA was investigated using circular dichroism (CD), 1H NMR and UV spectroscopies, along with CD melting. For these studies DNA was isolated from calf thymus (CT), salmon fish sperm (SS), and chicken erythrocyte (CE), however for our purposes an artificially constructed and highly purified plasmid DNA (pUC18) preparation proved to be the most suitable. DNA binding of the drug was confirmed by shifts in the characteristic CD bands of the DNA, the appearance of an induced CD (ICD) signal in the upper absorption region of sunitinib (300 nm-500 nm), and the evidence from CD melting studies and the NMR. Based on the CD and NMR measurements, it can be assumed that sunitinib has a multiple-step binding mechanism.


Molecular Cytogenetics | 2014

A de novo atypical ring sSMC(22) characterized by array CGH in a boy with cat-eye syndrome

Irén Haltrich; Henriett Pikó; Eszter Kiss; Zsuzsa Tóth; Veronika Karcagi; György Fekete

BackgroundMicroduplications 22q11 have been characterized as a genomic duplication syndrome mediated by nonallelic homologous recombination between region-specific low-copy repeats. Here we report on a 19 years old boy with intellectual disability having an unexpected structurally complex ring small supernumerary marker chromosome (sSMC) originated from a larger trisomy and a smaller tetrasomy of proximal 22q11 harboring additional copies of cat eye syndrome critical regions genes.ResultsPrincipal clinical features were: anorectal and urogenital malformations, total anomalous pulmonary venous return with secundum ASD, hearing defect, preauricular pits, seizure and eczema. The proband also presented some rare or so far not reported clinical findings such as hyperinsulinaemia, severe immunodeficiency and grave cognitive deficits.Chromosome analysis revealed a mosaic karyotype with the presence of a small ring-like marker in 60% of cells. Array CGH detected approximately an 1,2 Mb single and a 0,2 Mb double copy gain of the proximal long arm of chromosome 22. The 1,3 Mb intervening region of chromosome 22 from centromere to the breakpoints showed no copy alteration. The karyotype of the patient was defined as 47,XY,+mar[60]/46,XY[40].ish idic r(22)(q11.1.q11.21) × 4.arr 22q11(17,435, 645-18,656,678) × 3,(17,598,642-17,799,783) × 4 dn.ConclusionsThe present report is the first one with a detailed description of clinical presentation in a patient carrying an atypical size ring sSMC (22) analyzed by array CGH. The specialty of the finding is emphasized by the fact that although the patient had a mosaic sSMC and the amplified region was smaller than in typical cat eye syndrome cases, the clinical presentation was severe.


Pediatric Research | 1997

Molecular Genotype in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency in Hungarian Population 74

Miklós Garami; Anna Ferenczi; Eszter Kiss; Mária Sasváry-Székely; J. Sólyom; György Fekete

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a result of mutations in the CYP21B gene encoding steroid 21-hydroxylase enzyme(21-OH). To detect mutations of CYP21B gene in 141 Hungarian patients, we isolated DNA from whole blood and analyzed by allele specific PCR. The classical salt-losing (SL) form was diagnosed in 90 index cases, the classical non-salt-losing (NSL) form in 39 and the late-onset (LO) form in 12 patients. We detected deletion and the seven most common mutations. Percentage distribution of abnormalites was as follows: Deletion 9.85%, I2splice 41.9%, I173N 17.25%, V282L 8.09%, Q319stop 6.69%, R357W 7.04%, L308insT 4.92% and Cluster E6 0.35%. In 32 cases (11.26%) we were not able to determine the mutation. In conclusion, the splice site mutation in intron 2 (the G mutation in the position of 659) was found to be the most frequent mutation in 21-OHD. This study confirms genotype - phenotype association.


The Journal of Clinical Endocrinology and Metabolism | 1999

Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia

Anna Ferenczi; Miklós Garami; Eszter Kiss; Mónika Pék; Maria Sasvari-Szekely; Csaba Barta; Maria Staub; J. Sólyom; György Fekete


Orvosi Hetilap | 2001

[Significance of anti-nucleosome (anti-chromatin) auto-antibodies in systemic lupus erythematosus].

Eszter Kiss; Gabriella Lakos; Németh J; Sándor Sipka; G. Szegedi


Orvosi Hetilap | 1997

Immunomodulatory effect of pentoxifylline in Graves ophthalmopathy

C. Balázs; Eszter Kiss; A. Vámos; I. Molnár; N. R. Farid


Molecular Cytogenetics | 2015

Complex X chromosome rearrangement associated with multiorgan autoimmunity

Irén Haltrich; Henriett Pikó; Horolma Pamjav; Anikó Somogyi; Antónia Völgyi; Dezső David; Artúr Beke; Zoltán Garamvölgyi; Eszter Kiss; Veronika Karcagi; György Fekete


Orvosi Hetilap | 1987

[Epidemiologic study of immunopathological diseases in a population sample from Hajdú-Bihar County].

Tamási L; Dézsi A; Sonkoly I; Eszter Kiss; Balázs C; G. Szegedi


Orvosi Hetilap | 2000

Az antifoszfolipid-szindróma klinikai és laboratóriumi jellemzóinek összehasonlító vizsgálata.

Pál Soltész; Katalin Veres; Eszter Kiss; Gabriella Lakos; Ildikó Sonkoly; László Muszbek; G. Szegedi

Collaboration


Dive into the Eszter Kiss's collaboration.

Top Co-Authors

Avatar

G. Szegedi

University of Debrecen

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Henriett Pikó

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Veronika Karcagi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge